On the recordFebruary 23, 2021
I will say, for the Johnson & Johnson product, I am very curious to see how that product will be discussed at FDA's Advisory Committee on Friday.
Source
congress.govEditor's note · Context
Tillis expresses interest in the FDA's discussion on the Johnson & Johnson vaccine.
Share
More from Thom Tillis
Aug 4, 2026
It’s unfortunate that Todd Blanche, who I consider qualified for the job, will not be confirmed because of this reversal.
Jul 28, 2026
I don’t have any confidence in him anymore. I think he’s all over the place.
Jul 31, 2026
I will continue working in good faith to put an end [to] this legal and political albatross and prevent any potential misallocation of taxpayer dollars.
Jul 30, 2026
It gives the Democrats gold to mine between now and the election. This is about as politically tone deaf a posture as I have seen in this administration.
Other voices in this conversation
